Poly(ethylene terephthalate) (PET) is a highly useful synthetic polyester plastic that is widely used in daily life. However, the increase in postconsumer PET as plastic waste that is recalcitrant to biodegradation in landfills and the natural environment has raised worldwide concern. Currently, traditional PET recycling processes with thermomechanical or chemical methods also result in the deterioration of the mechanical properties of PET. Therefore, it is urgent to develop more efficient and green strategies to address this problem. Recently, a novel mesophilic PET-degrading enzyme (IsPETase) from Ideonella sakaiensis was found to streamline PET biodegradation at 30°C, albeit with a lower PET-degrading activity than chitinase or chitinase-like PET-degrading enzymes. Consequently, the molecular engineering of more efficient PETases is still required for further industrial applications. This review details current knowledge on IsPETase, MHETase, and IsPETase-like hydrolases, including the structures, ligand‒protein interactions, and rational protein engineering for improved PET-degrading performance. In particular, applications of the engineered catalysts are highlighted, including metabolic engineering of the cell factories, enzyme immobilization or cell surface display. The information is expected to provide novel insights for the biodegradation of complex polymers.
Polyethylene terephthalate (PET), a widely used synthetic polymer in daily life, has become a major source of post-consumer waste due to its complex molecular structure and resistance to natural degradation, which has posed a significant threat to the global ecological environment and human health. Current PET-processing methods include physical, chemical, and biological approaches, however each have their limitations. Given that numerous microbial strains exhibit a remarkable capacity to degrade plastic materials, microbial degradation of PET has emerged as a highly promising alternative. This approach not only offers the possibility of converting waste into valuable resources but also contributes to the advancement of a circular economy. Therefore in this review, it is mainly focused on the cutting-edge microbial technologies and the key role of specific microbial strains such as Ideonella sakaiensis 201-F6, which can efficiently degrade and assimilate PET. Particularly noteworthy are the catalytic enzymes related to the metabolism of PET, which have been emphasized as a sustainable and eco-friendly strategy for plastic recycling within the framework of a circular economy. Furthermore, the study also elucidates the innovative utilization of degraded plastic materials as feedstock for the production of high-value chemicals, highlighting a sustainable path forward in the management of plastic waste.
The objective of the investigation was to evaluate the percutaneous penetration of a ubidecarenone-loaded nanostructured lipid carrier (UB-NLC) and to illuminate the protective effects of UB-NLC for amelioration of hydrogen peroxide-induced oxidative damage on HaCaT cells. Ubidecarenone (UB) was encapsulated in a nanostructured lipid carrier (NLC), which was manufactured by homogenization. The morphological and dimensional properties of the prepared UB-NLC were studied by freeze-fracture transmission electron microscopy (FF-TEM) and photon correlation spectroscopy (PCS). Percutaneous penetration of UB-NLC was carried out by the Franz diffusion cells method. The change of cellular morphology was identified through a non-invasive time-lapse imaging system. The assessment was achieved via the evaluation of the levels of oxidative stress markers: reactive oxygen species (ROS), superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), and malondialdehyde (MDA). Percutaneous penetration of UB loaded in NLC formulation was enhanced in comparison to free UB. Preincubation of HaCaT cells with UB-NLC attenuated the level of intracellular generation of ROS. Lipid peroxidation was diminished by UB-NLC via inhibition of MDA formation. Pretreatment of cells with UB-NLC reestablished the activity of cellular antioxidant enzymes (SOD and GSH-PX). On the basis of the investigation conducted, results suggest that formulating UB as NLC is advantageous for topical delivery and treatment of oxidative stress-induced human diseases.
The release behaviour and kinetic evaluation of resveratrol (Res) from nanostructured lipid carrier (NLC) have been conducted after characterisation for Res‐NLC in this study. High‐pressure microfluidisation technique was successfully applied to manufacturing Res‐NLC, and the morphology of nanoparticle was observed via freeze‐fracture transmission electron microscopy. Photon correlation spectroscopy was used to characterise the NLC system for particle size (PS) and polydispersity index (PDI). The in vitro release research was implemented by the dialysis method with active ingredient determined by high‐performance liquid chromatography. Fitting of release data to different kinetic models was carried out. The optimised Res‐NLC was physically stable with the PS below 200 nm, PDI below 0.3 and zeta potential (ZP) above 50 mV. The encapsulation efficiency was above 80%. Moreover, an in vitro release analysis demonstrated the sustained release profile of contents from NLC formulation over 12 h, with about 90% of the active ingredient released. Res‐NLC presented the best fit with the Weibull model accompanied by better correlation value. In conclusion, all the obtained results demonstrated that the release study of Res‐loaded NLC exhibited the promising application of the NLC formulation system in active ingredient sustained release carrier.